Additionally, it raises the percentage of CD8+ T cells as well as CD86+CD11c+ dendritic cells within the spleen in vivo, upregulates serum IFN-γ levels, and increases the quantity and function of CD8+ T cells in tumor-draining lymph nodes. This evidence concerns the gene CD8A and neoplasm.